Latest Breaking News On - Patient impact - Page 3 : comparemela.com

UnitedHealthcare Accused of Using Faulty AI Model to Deny Healthcare Claims to Elderly Patients

UnitedHealthcare has been sued for allegedly using a faulty AI model to deny healthcare claims to elderly patients.

Verastem Oncology Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progres

Plan to Submit Application for Accelerated Approval for Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) in H1 2024Expects to Begin Enrollment in Phase 3 Confirmatory Trial, RAMP 301, of Avutometinib and Defactinib in LGSOC in Q4 2023Presented Additional Patient Subgroup Data for the.

Verastem Oncology Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress

Plan to Submit Application for Accelerated Approval for Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in H1 2024 Expects to Begin Enrollment in Phase 3 Confirmatory.

First-Of-Its-Kind, Multi-National Patient Impact Survey Reveals Unique Challenges and Gaps in Care for Patients with Low-Grade Serous Ovarian Cancer

Announcing the Digital In Vivo Alliance (DIVA), a precompetitive consortium to develop, validate and promote the use of AI-enabled digital biomarkers in preclinical in vivo research.

/PRNewswire/ A milestone event unfolds today with the announcement of the Digital In Vivo Alliance (DIVA), a precompetitive independent consortium of.